Wealth Watch Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-50
Closed -$2.56K – 726
2025
Q4
$2.56K Buy
+50
New +$2.31K ﹤0.01% 630

Other funds holding SBIO

Wealth Watch Advisors's SBIO Position: Q1 2026 in Review

Wealth Watch Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2026, closing a stake of 50 shares — an estimated $2.56K sold.

Wealth Watch Advisors first reported a position in SBIO in Q4 2025 and held it in 1 quarter. The position peaked at $2.56K in Q4 2025. 61 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

  • Wealth Watch Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2026 after selling out during the quarter.
  • Wealth Watch Advisors sold 50 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $2.56K.
  • Wealth Watch Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and held it in 1 quarter.
  • Wealth Watch Advisors's ALPS Medical Breakthroughs ETF position peaked at $2.56K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Wealth Watch Advisors's 13F filing for Q1 2026, filed 15 May 2026.